GMO US Value ETF
GMOV
13 hedge funds and large institutions have $19M invested in GMO US Value ETF in 2025 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 3 closing their positions.
500% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 1
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
35% more capital invested
Capital invested by funds: $14.1M → $19M (+$4.9M)
18% more funds holding
Funds holding: 11 → 13 (+2)
2.13% more ownership
Funds ownership: 26.62% → 28.75% (+2.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
+$1.82M |
| 2 |
MML Investors Services
Springfield,
Massachusetts
|
+$1.75M |
| 3 |
SG
StoneX Group
New York
|
+$1.5M |
| 4 |
RAS
RPS Advisory Solutions
Louisville,
Kentucky
|
+$471K |
| 5 |
JWCA
J.W. Cole Advisors
Tampa,
Florida
|
+$429K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$795K |
| 2 |
Envestnet Asset Management
Chicago,
Illinois
|
-$756K |
| 3 |
CFG
Certior Financial Group
King Of Prussia,
Pennsylvania
|
-$559K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$365K |
GMOV Hedge Fund Activity: Q4 2025 in Review
13 of the 8,252 institutional investors tracked by Wall St. Rank reported a position in GMO US Value ETF (GMOV) for Q4 2025, worth a combined $19M — up 35% from $14.1M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new GMOV positions and 3 closed out — a net gain of 2 holders — while 6 added to existing stakes and 1 trimmed.
The largest buyer was Grantham, Mayo, Van Otterloo & Co (GMO), opening a new position worth an estimated $1.82M. The largest seller was Citadel Advisors, exiting entirely with an estimated $795K sold.
- 13 institutional investors held GMO US Value ETF (GMOV) as of Q4 2025, up from 11 in Q3 2025.
- Funds reported $19M of GMO US Value ETF stock for Q4 2025, up 35% quarter-over-quarter.
- 5 funds opened new GMO US Value ETF positions in Q4 2025 and 3 closed out, a net change of +2 holders.
- The largest GMO US Value ETF buyer in Q4 2025 was Grantham, Mayo, Van Otterloo & Co (GMO), an estimated $1.82M added.
- The largest GMO US Value ETF seller in Q4 2025 was Citadel Advisors, an estimated $795K sold.
Based on aggregated 13F filings for Q4 2025.